A panel of oncologists discuss recent updates in the management of patients with myelofibrosis and share insight into their strategies for two case scenarios.
EP. 1: Diagnosis and Risk Stratification of Myelofibrosis
Srdan Verstovsek, MD, PhD, provides an overview of how myelofibrosis is diagnosed and what criteria are used for risk stratification.
EP. 2: Differences Between Types of Myelofibrosis
Aaron Gerds, MD, explains the various types of myelofibrosis and the underlying pathophysiologies.
EP. 3: The JAK/STAT Pathway and Myelofibrosis
Raajit Rampal, MD, describes the JAK-STAT pathway and how it’s fundamental to all types of myelofibrosis.
EP. 4: Clinical Scenario: Patient with Primary Myelofibrosis
Dr John Mascarenhas presents a patient case scenario of a 68-year-old woman with a common presentation of primary myelofibrosis.
EP. 5: Approved Treatments for Myelofibrosis
A review of the approved treatments for myelofibrosis, including dosing guidelines and supporting clinical trial data.
EP. 6: Therapy Strategies for Primary Myelofibrosis
Raajit Rampal, MD, PhD, shares the treatment options he would consider for the presented clinical scenario.
EP. 7: Treatments for Myelofibrosis Based on Platelet Counts
A panel of experts considers treatment options for patients with myelofibrosis based on platelet counts, while factoring in health insurance barriers.
EP. 8: Clinical Scenario: Myelofibrosis Treatment in the Second-Line Setting
John Mascarenhas, MD, presents a clinical scenario of a 73-year-old man with myelofibrosis and a low platelet count.
EP. 9: Approaches to Switching Treatments for Myelofibrosis
A discussion on when to switch a patient with myelofibrosis to a new JAK inhibitor treatment, and possible strategies for transitioning.
EP. 10: Considering Toxicities when Choosing Appropriate Treatment for Myelofibrosis
Raajit Rampal, MD, explains how he considers safety profiles when deciding on appropriate treatment for myelofibrosis and how he manages toxicities for patients.
EP. 11: Assessing Response to Treatment in Myelofibrosis
Dr Srdan Verstovsek shares how he assesses myelofibrosis treatment response in his clinical practice.
EP. 12: Sequencing Treatments for Myelofibrosis
A look at sequencing strategies for myelofibrosis treatments.
EP. 13: Unmet Needs in Myelofibrosis Treatment
Experts delve into the unmet needs in the myelofibrosis treatment landscape and highlight promising ongoing clinical trials.
EP. 14: Clinical Pearls for Community Oncologists Treating Myelofibrosis
The panel closes their discussion on myelofibrosis treatment updates by sharing clinical pearls for community oncologists.
2 Clarke Drive Cranbury, NJ 08512